very few Aussie's know about the products - wait for mass adoption across our population - I don't see why revenue from Aus alone won't get to $20-$30m pa in the short to medium term (currently $8-$10m pa off a very low number of consumers)
the fact that their wide range of products are clinically proven with no direct competition whatsoever is extremely exciting & should make shareholders proud!
disclaimer I own shares in ASX BIO
do not rely on anything I say
do your own homework & research
Ann: Investor webinar and investor hub, page-20
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.020(6.45%) |
Mkt cap ! $61.72M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 28.5¢ | $82.50K | 276.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 900 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 2213 | 1 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
29.0¢ |
Change
-0.020 ( 4.92 %) |
||||
| Open | High | Low | Volume | ||
| 31.0¢ | 31.0¢ | 28.5¢ | 86765 | ||
| Last updated 15.59pm 13/05/2024 ? | |||||
| BIO (ASX) Chart |